Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Intangibles (2021 - 2025)

Historic Intangibles for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to $231.9 million.

  • Mirum Pharmaceuticals' Intangibles fell 934.31% to $231.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.9 million, marking a year-over-year decrease of 934.31%. This contributed to the annual value of $249.8 million for FY2024, which is 122.8% down from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Intangibles of $231.9 million as of Q3 2025, which was down 934.31% from $237.9 million recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Intangibles peaked at $261.8 million during Q2 2024, and registered a low of $18.5 million during Q1 2022.
  • In the last 5 years, Mirum Pharmaceuticals' Intangibles had a median value of $231.9 million in 2025 and averaged $151.2 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Intangibles skyrocketed by 47367.65% in 2023, and later crashed by 934.31% in 2025.
  • Mirum Pharmaceuticals' Intangibles (Quarter) stood at $18.7 million in 2021, then surged by 214.59% to $59.0 million in 2022, then skyrocketed by 329.02% to $252.9 million in 2023, then dropped by 1.23% to $249.8 million in 2024, then fell by 7.17% to $231.9 million in 2025.
  • Its last three reported values are $231.9 million in Q3 2025, $237.9 million for Q2 2025, and $243.8 million during Q1 2025.